COWZ vs XBI
Pacer US Cash Cows 100 ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.49% for COWZ.
- • COWZ pays a higher dividend yield (1.91%).
Side-by-side metrics
| Metric | COWZ | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.49% | 0.35% |
Dividend yield Trailing 12-month yield. | 1.91% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $19.78B | $10.92B |
YTD return | 18.58% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.62 | 1.01 |
P/E ratio | 15.96 | — |
Last price | $71.07 | $156.41 |
Inception | — | — |
Issuer | Pacer | State Street |
COWZ top holdings
| ACN | Accenture PLC Class A | 2.76% |
| LMT | Lockheed Martin Corp | 2.42% |
| COP | ConocoPhillips | 2.29% |
| MPC | Marathon Petroleum Corp | 2.28% |
| MO | Altria Group Inc | 2.26% |
| GILD | Gilead Sciences Inc | 2.25% |
| CVX | Chevron Corp | 2.25% |
| IBM | International Business Machines Corp | 2.19% |
| VLO | Valero Energy Corp | 2.15% |
| PFE | Pfizer Inc | 2.14% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About COWZ
COWZ (Pacer US Cash Cows 100 ETF) is 100 Russell 1000 stocks with highest free cash flow yield. Managed by Pacer, the fund carries $19.8B in assets under management, an expense ratio of 0.49%, a dividend yield of 1.91%. Its largest holding is Accenture PLC Class A (ACN), which represents 2.8% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 9.6%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.